Simone König

Prof. Simone König

University of Münster
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 1999 in Biochemistry
Verified
Journal Article
Closed access
WBWilliam C. Barrett
William C. Barrett
JDJon P. DeGnore
Jon P. DeGnore
Simone KönigSimone König
Simone König
HFHenry M. Fales
Henry M. Fales
YKYen-Fang Keng
Yen-Fang Keng
PCP. Boon Chock
P. Boon Chock

1 September 2011 in Neuron
Verified
Journal Article
Closed access
MKMarkus P. Kummer
Markus P. Kummer
MHMichael Hermes
Michael Hermes
ADAndrea Delekarte
Andrea Delekarte
THThea Hammerschmidt
Thea Hammerschmidt
SKSathish H.S. Kumar
Sathish H.S. Kumar
MHMichael T. Heneka
Michael T. Heneka

3 April 2018 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
TVThomas Vogl
Thomas Vogl
ASAthanasios Stratis
Athanasios Stratis
VWViktor Wixler
Viktor Wixler
TVTom Völler
Tom Völler
STSumita Thurainayagam
Sumita Thurainayagam
JRJohannes Roth
Johannes Roth
Autoimmune diseases, such as psoriasis and arthritis, show a patchy distribution of inflammation despite systemic dysregulation of adaptive immunity. Thus, additional tissue-derived signals, such as danger-associated molecular patterns (DAMPs), are indispensable for manifestation of local inflammation. S100A8/S100A9 complexes are the most abundant DAMPs in many autoimmune diseases. However, regulatory mechanisms locally restricting DAMP activities are barely understood. We now unravel for the first time, to our knowledge, a mechanism of autoinhibition in mice and humans restricting S100-DAMP activity to local sites of inflammation. Combining protease degradation, pull-down assays, mass spectrometry, and targeted mutations, we identified specific peptide sequences within the second calcium-binding EF-hands triggering TLR4/MD2-dependent inflammation. These binding sites are free when S100A8/S100A9 heterodimers are released at sites of inflammation. Subsequently, S100A8/S100A9 activities are locally restricted by calcium-induced (S100A8/S100A9)2 tetramer formation hiding the TLR4/MD2-binding site within the tetramer interphase, thus preventing undesirable systemic effects. Loss of this autoinhibitory mechanism in vivo results in TNF-α–driven fatal inflammation, as shown by lack of tetramer formation in crossing S100A9–/– mice with 2 independent TNF-α–transgene mouse strains. Since S100A8/S100A9 is the most abundant DAMP in many inflammatory diseases, specifically blocking the TLR4-binding site of active S100 dimers may represent a promising approach for local suppression of inflammatory diseases, avoiding systemic side effects.

27 May 2012 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
AHAlexander S Hahn
Alexander S Hahn
JKJohanna K Kaufmann
Johanna K Kaufmann
EWEffi Wies
Effi Wies
ENElisabeth Naschberger
Elisabeth Naschberger
JPJulia Panteleev-Ivlev
Julia Panteleev-Ivlev
FNFrank Neipel
Frank Neipel

31 March 2011 in Proteomics
Verified
Journal Article
Closed access
PDF file
AKAndré Kriegeskorte
André Kriegeskorte
Simone KönigSimone König
Simone König
GSGunnar Sander
Gunnar Sander
APAlexander Pirkl
Alexander Pirkl
EMEsther Mahabir
Esther Mahabir
Karsten BeckerKarsten Becker
Karsten Becker

1 June 2003 in Molecular Biology of the Cell
Verified
Journal Article
Closed access
MKMax Koltzscher
Max Koltzscher
CNClaudia Neumann
Claudia Neumann
Simone KönigSimone König
Simone König
VGVolker Gerke
Volker Gerke
S100 proteins are EF hand type Ca2+ binding proteins thought to function in stimulus-response coupling by binding to and thereby regulating cellular targets in a Ca2+-dependent manner. To isolate such target(s) of the S100P protein we devised an affinity chromatography approach that selects for S100 protein ligands requiring the biologically active S100 dimer for interaction. Hereby we identify ezrin, a membrane/F-actin cross-linking protein, as a dimer-specific S100P ligand. S100P-ezrin complex formation is Ca2+ dependent and most likely occurs within cells because both proteins colocalize at the plasma membrane after growth factor or Ca2+ ionophore stimulation. The S100P binding site is located in the N-terminal domain of ezrin and is accessible for interaction in dormant ezrin, in which binding sites for F-actin and transmembrane proteins are masked through an association between the N- and C-terminal domains. Interestingly, S100P binding unmasks the F-actin binding site, thereby at least partially activating the ezrin molecule. This identifies S100P as a novel activator of ezrin and indicates that activation of ezrin's cross-linking function can occur directly in response to Ca2+ transients.